✦ LIBER ✦

9006 Safety of bevacizumab (BV) combined with chemotherapy (CTX) in patients (pts) with non-small cell lung cancer (NSCLC): interim results from the ARIES Lung observational cohort study (OCS)

✍ Scribed by Jahanzeb, M.; Fischbach, N.; Kosty, M.; Kumar, P.; Spigel, D.; Wozniak, A.; Teng, S.L.; Wang, L.; Sing, A.; Lynch, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9073 POSTER Clinical Outcomes for Bevaci

✍ Wozniak, A.; Kosty, M.R.; Jahanzeb, M.; Garst, J.; Spigel, D.; Leon, L.; Fish, S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

9020 POSTER DISCUSSION Use of Bevacizuma

✍ Kostv, M.P.; Brahmer, J.R.; Jahanzeb, M.; Kumar, P.; Robles, R.; Wozniak, A.J.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

9170 Safety and efficacy of first-line b

✍ Garrido, P.; Thatcher, N.; Crino, L.; Dansin, E.; Laskin, J.; Pavlakis, N.; Tsai 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

9165 Motesanib or bevacizumab in combina

✍ Blumenschein, G.; Schwartzberg, L.S.; Menon, H.; Mok, T.S.K.; Stephenson, J.J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

9172 Analysis of biomarkers (BMs) in the

✍ Leighl, N.; Reck, M.; de Haas, S.; Evers, S.; Delmar, P.; Manegold, C.; Scherer, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Results of the phase I-II study of gemci

✍ Faivre, S; Monnerat, C; Raymond, E; Taieb, J; Adi Vago, N; Vicente-Azevedo, J; R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB